Atlas FDA

ARCHITECT AUSAB, Alinity i Anti-HBs

FDA premarket approval P050051/S043 · decided 2022-04-14

Approval details

PMA number
P050051
Supplement
S043
Supplement type
Normal 180 Day Track
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
ARCHITECT AUSAB, Alinity i Anti-HBs
Generic name
Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)
Applicant
Abbott Laboratories, Inc.
Date received
2021-09-28
Decision date
2022-04-14
Days to decision
198 days
Decision code
APPR
Product code
LOM
Advisory committee
Microbiology
Expedited review
No
Location
Abbott Park, IL
Statement
Approval for conversion of the microparticle coating process from an automated microparticle processing system to a magnetic separation coating process.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
ARCHITECT IVALPROIC ACID REAGENTS AND ARCHITECT IVALPROIC ACID CALIBRATORS, MODELS 1P35, 1P35 (K090358)Abbott Laboratories, Inc.2009-08-06
CREATININE (K061193)Abbott Laboratories, Inc.2006-06-23
PRECISION XTRA PLUS OR OPTIUM PLUS, BLOOD GLUCOSE TEST STRIPS (K051213)Abbott Laboratories, Inc.2005-05-27
FOX PLUS PTA CATHETER (K040954)Abbott Laboratories, Inc.2004-05-11
AXSYM CYCLOSPORINE (K040761)Abbott Laboratories, Inc.2004-04-30
GEMSTAR INFUSION PUMP SYSTEM, 7 THERAPY, 6 THERAPY & PAIN MANAGEMENT (K023062)Abbott Laboratories, Inc.2002-09-30